Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Disease Information
History
Genetics
Molecular basis
Classification
Signs, Symptoms & Clinical Presentation
Diagnosis
Management of Gaucher disease
Medical Information Services
Gaucher Registry
Practical Information
Request Materials
Fabry
MPS I
Pompe

 



 

Disease Classification

Gaucher disease is a panethnic disorder. It has been divided into three types based on the presence and severity of neurological involvement:

Type 1 (non-neuronopathic)

The most common type, it afflicts both children and adults. This type is more prevalent in people of Ashkenazi Jewish ancestry.[1]

Type 2 (acute neuronopathic) and Type 3 (chronic neuronopathic)

These less common forms of the disease are characterized by central nervous system involvement. Type 2 patients rarely survive to age 2. Type 3 is characterized by a variable course and is marked by slowly progressive neurological involvement.[2]

Gaucher disease approximate frequency, onset, and course by type [1, 2, 3, 4]

In Genetics, you can learn more about the inheritance of this autosomal recessive disorder.

Go to Signs and Symptoms to learn about the wide-ranging effects of Gaucher disease.

References

1. Morales LE. Gaucher's disease: a review. Ann Pharmacother. 1996;30:381-388.

2. Grabowski GA. Lysosomal storage diseases. In: Braunwald E, Fauci AS, eds. Harrison's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001:2276-2281.

3. Zimran A, Gelbart T, Westwood B, et al. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet. 1991;49:855-859.

4. Beutler E, Grabowski G. Gaucher disease. In:Scriber CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995;2:2641-2661.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease